HIV Treatment Bulletin
A community publication produced every 2-3 weeks. HTB reviews the most important advances in the clinical management of HIV and access to treatment.
Although HTB used to be a printed publication, it is now only distributed in electronic format: online, by email and in RSS and PDF format.
As a technical bulletin, estimated readership is 5000 doctors and other health professionals in the UK and internationally. Approximately 5% of readers are people living with HIV.
Regular contributors include:
Nathan Geffen, South Africa
Gareth Hardy, London
Richard Jefferys, New York
HTB is distributed by email alert, RSS feed, online html pages and in PDF formats.
- HTB South – Focus on southern Africa
- HIV Tedavi Bülteni (HTB Turkey) – Produced in Turkey
- HIV Bilten (HTB West Balkans) – Published in Bosnian, Montenegrin, Croatian and Serbian.
- ARV4IDUs – HIV treatment and IDUs (no longer produced)
Medical review board
Each edition of HTB is circulated for comments to the following medical review board, who support the publication with the benefit of their experience.
Dr Tristan Barber, Royal Free Hospital, London.
Dr Karen Beckerman, Albert Einstein College of Medicine, NYC.
Dr Sanjay Bhagani, Royal Free Hospital, London.
Professor Diana Gibb, Medical Research Council, London.
Dr Gareth Hardy, PhD.
Professor Saye Khoo, University of Liverpool Hospital.
Professor Clive Loveday, International Laboratory Virology Centre.
Professor James McIntyre, Chris Hani Baragwanath Hospital. South Africa.
Dr Graeme Moyle, Chelsea & Westminster Hospital, London.
Dr Stefan Mauss, Düsseldorf.
Professor Caroline Sabin, UCL Medical School, London.
Dr Graham P Taylor, Imperial College, London.
Dr Stephen Taylor, Birmingham Heartlands Hospital.
Dr Gareth Tudor-Williams, Imperial College, London.
Dr Edmund Wilkins, Manchester General Hospital, Manchester.
In addition to the support provided by our medical and community review boards, i-Base work closely with a range of other organisations.
Editorial policy, copyright and funding
Comments to articles are compiled from consultant, author and editorial responses.
Some articles are reproduced from other respected sources and copyright for these articles remains with the original authors and sources, as indicated at the end of each article.
We thank those organisations for recognising the importance of providing widely distributed free access to information both to people living with HIV and to the healthcare professionals involved in their care. We also thank them for permission to distribute their excellent work and we encourage htb readers to visit the source websites for further access to their coverage of HIV treatment.
Articles written and credited to i-Base writers, as with all i-Base originated material, remains the copyright of HIV i-Base, but these articles may be reproduced by community and not-for-profit organisations without individual written permission and reproduction is encouraged. A credit and link to the original author, the HTB issue and the i-Base website is always appreciated.
HIV i-Base receives unconditional educational grants from charitable trusts, individual donors and pharmaceutical companies. All editorial policies are strictly independent of funding sources.